CoChat

Incident Type 2 Diabetes Duration and Cancer Risk: A Prospective Study in Two US Cohorts

Open access
Hu, Yang, Zhang, Xuehong, Ma, Yanan, Yuan, Chen, Wang, Molin, Wu, Kana, Tabung, Fred K, Tobias, Deirdre, Hu, Frank B, Giovannucci, Edward, Song, Mingyang · 2021 · JNCI: Journal of the National Cancer Institute
Cited by 116

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

Background: The influence of type 2 diabetes mellitus (T2D) duration on cancer incidence remains poorly understood. Methods: We prospectively followed for cancer incidence 113 429 women in the Nurses’ Health Study (1978-2014) and 45 604 men in the Health Professionals Follow-up Study (1988-2014) who were free of diabetes and cancer at baseline. Cancer incidences were ascertained by review of medical records. Results: In the multivariable-adjusted model incident, T2D was associated with higher risk of cancers in the colorectum, lung, pancreas, esophagus, liver, thyroid, breast, and endometrium. The pooled hazard ratios (HRs) ranged from 1.21 (95% confidence interval [CI] = 1.06 to 1.38) for colorectal cancer to 3.39 (95% CI = 2.24 to 5.12) for liver cancer. For both composite cancer outcomes and individual cancers, the elevated risks did not further increase after 8 years of T2D duration. The hazard ratio for total cancer was 1.28 (95% CI = 1.17 to 1.40) for T2D duration of 4.1-6.0 years, 1.37 (95% CI = 1.25 to 1.50) for 6.1-8.0 years, 1.21 (95% CI = 1.09 to 1.35) for 8.1-10.0 years, and 1.04 (95% CI = 0.95 to 1.14) after 15.0 years. In a cross-sectional analysis, a higher level of plasma C-peptide was found among participants with prevalent T2D of up to 8 years than those without T2D, whereas a higher level of HbA1c was found for those with prevalent T2D of up to 15 years. Conclusions: Incident T2D was associated with higher cancer risk, which peaked at approximately 8 years after diabetes diagnosis. Similar duration-dependent pattern was observed for plasma C-peptide. Our findings support a role of hyperinsulinemia in cancer development.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/jnci/djaa141

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

See all 116

Metadata

Authors
Hu, Y., Zhang, X., Ma, Y., Yuan, C., Wang, M., Wu, K., Tabung, F. K., Tobias, D., Hu, F. B., Giovannucci, E., & Song, M.
Venue
JNCI: Journal of the National Cancer Institute
Published
2020-09-16
Volume
113
Issue
4
Pages
381-389
ISSN
  • 0027-8874 (ISSN-L)
  • 1460-2105
OpenAlex
W3109932998
Cited by
116
References
6
FWCI
4.49
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Incident Type 2 Diabetes Duration and Cancer Risk: A Prospective Study in Two US Cohorts. https://app.cochat.ai/papers/10.1093/jnci/djaa141
The paper
Hu, Y., Zhang, X., Ma, Y., Yuan, C., Wang, M., Wu, K., Tabung, F. K., Tobias, D., Hu, F. B., Giovannucci, E., & Song, M. (2021). Incident Type 2 Diabetes Duration and Cancer Risk: A Prospective Study in Two US Cohorts. JNCI: Journal of the National Cancer Institute. https://doi.org/10.1093/jnci/djaa141

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.